These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 136425)
21. Neuropsychopharmacology and the affective disorders (second of three parts). Schildkraut JJ N Engl J Med; 1969 Jul; 281(5):248-55. PubMed ID: 4892998 [No Abstract] [Full Text] [Related]
22. Role of biogenic amines in the effects of marijuana on EEG patterns in cats. Adams PM; Barratt ES Electroencephalogr Clin Neurophysiol; 1975 Dec; 39(6):621-5. PubMed ID: 53140 [TBL] [Abstract][Full Text] [Related]
23. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900 [TBL] [Abstract][Full Text] [Related]
24. Neurochemical and neuropharmacological aspects of depression. Leonard BE Int Rev Neurobiol; 1975; 18():357-87. PubMed ID: 1354 [No Abstract] [Full Text] [Related]
25. The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge. Wilkison DM; Halpern LM J Pharmacol Exp Ther; 1979 Oct; 211(1):151-8. PubMed ID: 158641 [No Abstract] [Full Text] [Related]
26. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS. Fuxe K; Hökfelt T Triangle; 1971; 10(3):73-84. PubMed ID: 5138525 [No Abstract] [Full Text] [Related]
28. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds. Buterbaugh GG; London ED Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247 [No Abstract] [Full Text] [Related]
29. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078 [No Abstract] [Full Text] [Related]
30. Effect of drugs on amines in the CNS. Sulser F; Sanders-Bush E Annu Rev Pharmacol; 1971; 11():209-30. PubMed ID: 4948498 [No Abstract] [Full Text] [Related]
31. Serotonin and severe affective disorders. McLeod WR; McLeod MF Aust N Z J Psychiatry; 1971 Dec; 5(4):289-95. PubMed ID: 5292061 [No Abstract] [Full Text] [Related]
32. Lithium--myth or magic. Ashcroft GW Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1320-2. PubMed ID: 4591694 [No Abstract] [Full Text] [Related]
33. Yohimbine: behavioral and biochemical effects in mice. Sanghvi I; Gershon S Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277 [No Abstract] [Full Text] [Related]
34. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Shopsin B; Gershon S; Goldstein M; Friedman E; Wilk S Psychopharmacol Commun; 1975; 1(2):239-49. PubMed ID: 131359 [TBL] [Abstract][Full Text] [Related]
35. Biogenic amines and head twitches in mice during ethanol withdrawal. Collier HO; Hammond MD; Schneider C Br J Pharmacol; 1974 Jun; 51(2):310-1. PubMed ID: 4281336 [TBL] [Abstract][Full Text] [Related]